Bruker Cellular Analysis published new research exploring a discovery-to-function workflow for CEACAM6-targeted ADCs using the Beacon Optofluidic platform for single-cell antibody discovery.
Published
Signal category
Research & Knowledge
Quote
“New research on CEACAM6-targeted ADCs explores a discovery-to-function workflow, using the Beacon® Optofluidic platform for single-cell antibody discovery before evaluating how surface engagement and internalization relate to ADC potency.”
— Bruker Cellular Analysis team
Company
Bruker Cellular Analysis
Understand The Life of Single Cells
- Industry
- Biotechnology Research
- Location
- Emeryville, US
- Company size
- 108 employees
At Bruker Cellular Analysis, our mission is to transform live single cell biology research through cutting-edge, science-driven technologies that enable researchers to study cellular function and molecular mechanisms with unmatched precision and insight. By integrating advanced optofluidics, live single-cell imaging, functional cell biology, and multiomic data, we unravel complex biology to accelerate critical scientific discoveries and therapeutic innovations. We are committed to partnering with leading visionary scientists in academia, biotech and pharmaceutical companies, and contract research organizations, providing them with high-throughput, reliable tools to drive impactful translational research that leads to improved patient outcomes. At the core of our philosophy is a customer-centric approach, delivering customized solutions and dependable support that enhance research efficiency and success. Our technologies empower breakthroughs in cell therapy, therapeutic antibody discovery, vaccine development, cell line development, and beyond.
Founded 2023